Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

KN Zabegalov, TO Kolesnikova, SL Khatsko… - European Journal of …, 2018 - Elsevier
Antidepressant drugs are currently one of the most prescribed medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further …

New insights on the antidepressant discontinuation syndrome

BH Harvey, FN Slabbert - … Psychopharmacology: Clinical and …, 2014 - Wiley Online Library
Objective Antidepressants are at best 50–55% effective. Non‐compliance and the
antidepressant discontinuation syndrome (ADS) are causally related yet poorly appreciated …

Antidepressant discontinuation syndrome: A state-of-the-art clinical review

M Fornaro, CI Cattaneo, D De Berardis… - European …, 2023 - Elsevier
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …

Antidepressant‐like effects and basal immobility depend on age and serotonin transporter genotype

NC Mitchell, W Koek, LC Daws - Genes, Brain and Behavior, 2015 - Wiley Online Library
Monoamine uptake inhibitors are common treatments for depression; however, the
therapeutic efficacy of these drugs varies widely. Two factors that are commonly linked to …

[HTML][HTML] Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms …

T Renoir - Frontiers in Pharmacology, 2013 - frontiersin.org
Besides demonstrated efficacy, selective serotonin reuptake inhibitors (SSRIs) hold other
advantages over earlier antidepressants such as greater tolerability and a wider range of …

[HTML][HTML] Mechanisms of antidepressant resistance

W El-Hage, S Leman, V Camus… - Frontiers in …, 2013 - frontiersin.org
Depression is one of the most frequent and severe mental disorder. Since the discovery of
antidepressant (AD) properties of the imipramine and then after of other tricyclic compounds …

Modeling treatment-resistant depression

BA Samuels, ED Leonardo, R Gadient, A Williams… - …, 2011 - Elsevier
Depression is a polygenic and highly complex psychiatric disorder that is currently a major
burden on society. Depression is highly heterogeneous in presentation and frequently …

Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models

T Renoir, TY Pang, L Lanfumey - Neuroscience & Biobehavioral Reviews, 2012 - Elsevier
This review discusses recent research of mood disorders associated with the cessation of
psychoactive substances, with an emphasis on preclinical studies that have been published …

[HTML][HTML] Pharmacogenetics and depression: a critical perspective

F Corponi, C Fabbri, A Serretti - Psychiatry investigation, 2019 - ncbi.nlm.nih.gov
Depression leads the higher personal and socio-economical burden within psychiatric
disorders. Despite the fact that over 40 antidepressants (ADs) are available, suboptimal …

[HTML][HTML] Discontinuing antidepressants: pearls and pitfalls

SJ Zwiebel, AC Viguera - Cleveland Clinic Journal of Medicine, 2022 - ccjm.org
Stopping antidepressants can be challenging due to the high rate of discontinuation
symptoms. Patients with antidepressant discontinuation syndrome (ADS) commonly …